Intra-arterial infusions stand at the forefront of innovative medical interventions, serving as a strategic conduit for delivering specialized treatments directly to designated arteries. This advanced therapeutic approach involves the meticulous administration of medicinal compounds, ranging from potent drugs to imaging agents, directly into the arterial system. The distinctive advantage of intra-arterial infusions lies in their precision, enabling the concentration of therapeutic effects to a specific anatomical site. This targeted delivery mechanism not only enhances treatment efficacy but also minimizes the impact on the broader systemic circulation, paving the way for a more refined and personalized medical strategy. The integration of intra-arterial infusions is prominently featured in the realm of interventional medicine, where skilled practitioners harness its potential to address diverse medical conditions. Cancer treatments, in particular, benefit significantly from this technique, as it allows for the direct administration of chemotherapy drugs to the tumor site. Moreover, intra-arterial infusions find application in the realm of vascular disorders, contributing to the management of conditions such as arterial blockages or aneurysms.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain